SunFire Biotechnologies LLC is a Birmingham-based company that specializes in the development of technologies for pneumococcal vaccine studies. Founded by Dr. Moon Nahm and a team of experienced professionals, SunFire focuses on the invention and utilization of the MOPA multiplexed opsonophagocytosis assay, which is widely used to evaluate pneumococcal vaccines, particularly in children and older adults.
With a strong emphasis on research and development, SunFire has received funding from the US government to refine a multiplexed serum bactericidal assay for functional antibodies against Shigella bacteria. The company's expertise extends beyond pneumococcal vaccines, as they also have significant experience with other analytical assays for pneumococci and other pathogens.
Generated from the website